Applications

Pure Protein’s soluble HLA method is useful for a number of important healthcare and research applications, and our suite of related analytical methods around this technology meet the diverse needs of the clinical or research laboratory.

Transplant Medicine

Pure Transplant Solutions, a wholly owned subsidiary of Pure Protein, uses the power of soluble HLA production to create tools specifically for organ and tissue transplant and for transfusion medicine. PTS is now offering HLA Sequence-Based Typing (SBT) services. <more>

Vaccine Development

Pure Vaccine Solutions, a wholly owned subsidiary of Pure Protein, is focused on the globally important area of vaccine development and validation. Pure Vaccine provides a complete system of HLA based vaccine design. At every step in the process, HLA is used to feedback information as to how design decisions will impact epitope presentation and effectiveness. <more>

HLA Proteomics

Pure Protein’s system for comparing the differences between diseased and healthy cells using HLA proteomics eliminates many biases inherent in biological and RNA array techniques. Our soluble HLA approach has the advantage of being a reproducible, standardized method of directly viewing the presentation of vaccine targets by MHC molecules. <more>